cetaben

Also Known As:

4-(hexadecylamino)benzoic acid; 4-(hexadecylamino)benzoic acid, monosodum salt; Benzoic acid, 4-(hexadecylamino)-, monosodium salt; cetaben, monosodium salt; p-hexadecylaminobenzoate sodium; sodium 4-(hexadecylamino)benzoate; sodium p-hexadecylaminobenzoate

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzoates: 426
        Aminobenzoates: 1
        para-Aminobenzoates: 43
        cetaben: 6
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Benzoates: 426
      - Aminobenzoates: 1
        para-Aminobenzoates: 43
        cetaben: 6

Experts

1.	Kovacs, W: 2 articles (06/2001 - 06/2001)
2.	Stangl, H: 2 articles (06/2001 - 06/2001)
3.	Kovacs, Werner J: 1 article (08/2004)
4.	Schrader, Michael: 1 article (08/2004)
5.	Stangl, Herbert: 1 article (08/2004)
6.	Walter, Ingrid: 1 article (08/2004)
7.	Baumgart, E: 1 article (06/2001)
8.	Dariush Fahimi, H: 1 article (06/2001)
9.	Schad, A: 1 article (06/2001)
10.	Völkl, A: 1 article (06/2001)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 06/01/2001 - "Our results indicate that cetaben represents an extraordinary type of peroxisomal proliferator with pleiotropic effects on human and rat hepatoma cells, and, at least in the human hepatoma cell line HepG2, these effects are not restricted to peroxisome proliferation." 06/01/2001 - "Human HepG2 and rat MH1C1 hepatoma cell lines were examined for their response to cetaben, an exceptional type of peroxisome proliferator. " 06/01/2001 - "Cetaben-induced changes on the morphology and peroxisomal enzymes in MH1C1 rat hepatoma cells and HepG2 human hepatoblastoma cells." 08/01/2004 - "The human hepatoma cell line HepG2 was used to study the effect of cetaben, a non-fibrate hypolipidemic drug, on cell morphology and vesicle distribution. " 06/01/2001 - "This is also confirmed by divergent results of treatment of hepatoma cell lines with clofibrate and cetaben on mRNA levels of catalase and acyl-CoA oxidase. "
2.	Hepatoblastoma 06/01/2001 - "Cetaben-induced changes on the morphology and peroxisomal enzymes in MH1C1 rat hepatoma cells and HepG2 human hepatoblastoma cells." 11/01/1995 - "Human (HepG2) and rat (MH1C1) hepatoblastoma cells were incubated with different concentrations of the hypolipidaemics cetaben, clofibrate and thyroxine. "
3.	Atherosclerosis 11/01/1978 - "Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkey."
4.	Starvation 08/01/2004 - "Changes in the intracellular cholesterol content are known to influence the intracellular vesicle distribution and are most likely responsible for cetaben-induced Golgi alterations, as depletion of cellular cholesterol by starvation or lovastatin and/or cyclodextrin treatment resulted in a similar redistribution of Golgi-derived wheat germ agglutinin vesicles. "
5.	Body Weight (Weight, Body) 11/01/1983 - "Cetaben caused 1 death at 200 mg/kg per day and decreases in body weight gain and food consumption at 50 mg/kg per day or more. "

Related Drugs and Biologics

1.	Fibric Acids (Fibrates)
2.	Hypolipidemic Agents (Antihyperlipidemics)
3.	Clofibrate
4.	Acyl-CoA Oxidase
5.	Wheat Germ Agglutinins
6.	Thyroxine (Levothyroxine)
7.	Messenger RNA (mRNA)
8.	Lovastatin (Mevacor)
9.	Enzymes
10.	Clodronic Acid (Clodronate)